Research Output per year
Research Output per year
Personal profile
Research Interests
DNA methylation and immunomodulatory pathways in ovarian cancer
Expertise related to UN Sustainable Devlopment Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
PhD, Seoul National University
… → 2007
Fingerprint
Dive into the research topics where Hao Huang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis
Wang, Y., Zhao, G., Condello, S., Huang, H., Cardenas, H., Tanner, E. J., Wei, J. J., Ji, Y., Li, J., Tan, Y., Davuluri, R. V., Peter, M. E., Cheng, J. X. & Matei, D., Jan 15 2021, In: Cancer Research. 81, 2, p. 384-399 16 p.Research output: Contribution to journal › Article › peer-review
19 Scopus citations -
Loss of host tissue transglutaminase boosts antitumor T cell immunity by altering STAT1/STAT3 phosphorylation in ovarian cancer
Sima, L. E., Chen, S., Cardenas, H., Zhao, G., Wang, Y., Ivan, C., Huang, H., Zhang, B. & Matei, D., Sep 30 2021, In: Journal for immunotherapy of cancer. 9, 9, e002682.Research output: Contribution to journal › Article › peer-review
Open Access -
FTO-Dependent N6-methyladenosine modifications inhibit ovarian cancer stem cell self-renewal by blocking cAMP signaling
Huang, H., Wang, Y., Kandpal, M., Zhao, G., Cardenas, H., Ji, Y., Chaparala, A., Tanner, E. J., Chen, J., Davuluri, R. V. & Matei, D., Aug 15 2020, In: Cancer Research. 80, 16, p. 3200-3214 15 p.Research output: Contribution to journal › Article › peer-review
33 Scopus citations -
Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmC
Li, C., Dong, L., Su, R., Bi, Y., Qing, Y., Deng, X., Zhou, Y., Hu, C., Yu, M., Huang, H., Jiang, X., Li, X., He, X., Zou, D., Shen, C., Han, L., Sun, M., Skibbe, J., Ferchen, K., Qin, X. & 5 others, , 2020, In: Haematologica. 105, 1, p. 148-160 13 p.Research output: Contribution to journal › Article › peer-review
Open Access15 Scopus citations -
Erratum: Publisher Correction: miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia (Nature communications (2012) 3 (688))
Li, Z., Huang, H., Chen, P., He, M., Li, Y., Arnovitz, S., Jiang, X., He, C., Hyjek, E., Zhang, J., Zhang, Z., Elkahloun, A., Cao, D., Shen, C., Wunderlich, M., Wang, Y., Neilly, M. B., Jin, J., Wei, M., Lu, J. & 10 others, , Apr 10 2018, In: Nature communications. 9, p. 16192 1 p., 16192.Research output: Contribution to journal › Comment/debate › peer-review
Open Access1 Scopus citations